Previous 10 | Next 10 |
Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C. PR Newswire SALT LAKE CITY , Aug. 18, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented pl...
Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand PR Newswire SALT LAKE CITY , Aug. 16, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique,...
2023-08-10 17:37:02 ET Co-Diagnostics, Inc. (CODX) Q2 2023 Earnings Call Transcript August 10, 2023 04:30 PM ET Company Participants Andrew Benson - Head, Investor Relations Dwight Egan - Chief Executive Officer Brian Brown - Chief Financial Officer Confere...
2023-08-10 16:02:45 ET Co-Diagnostics press release ( NASDAQ: CODX ): Q2 GAAP EPS of -$0.31 misses by $0.07 . Revenue of $0.2M (-96.0% Y/Y) misses by $0.3M . For further details see: Co-Diagnostics GAAP EPS of -$0.31 misses by $0.07, revenue of $0.2M miss...
Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results PR Newswire Co-Dx receives grant awards from the Bill & Melinda Gates Foundation; NIH RADx® Tech to develop tests on our new Co-Dx PCR Home™ platform SALT LAKE CITY , Aug. 10, ...
Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 27, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CA PR Newswire SALT LAKE CITY , July 20, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wit...
Co-Diagnostics, Inc. Announces Recent Grant Awards PR Newswire The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis and HPV tests for its Co-Dx PCR Home™ platform SALT LAKE CITY , Jul...
2023-07-17 04:13:30 ET Summary The company's stock, which was trading at $6.13 in April 2022, is now trading at $1.35, a ~77% discount. It has multiple products but none have reported meaningful revenues to make up for its dwindling COVID test revenues. Management has withheld...
Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program PR Newswire The Company intends to use the funds awarded by the National Institutes of Health for completion of its upper respiratory panel multiplex on Co-Dx PCR Home™ p...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 PR Newswire SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented plat...